Immunomodulators Part B

1. Microbiome and microbial products as immunomodulators: Implications for gastrointestinal cancers<br>Shriyans Reddy Yendreddy, Divya Patchigolla, Satyendra Singh, Kirti Baghel, Rupal Ojha, and Vijay Kumar Prajapati<br>2. VISTA as a Double-Edged immune checkpoint molecule in cancer and autoimmunity<br>Ali Mert Sencer and Sibel Kalyoncu<br>3. Investigating the immune modulatory association of miRNAs in HPV-associated HNSCC individuals: A bioinformatics approach<br>Ankur Datta, M. Muthu Meenakshi, Susanna Daniels, B. Varsha, and C. George Priya Doss<br>4. Transcriptomic Insights into Epigenetic and Immunomodulatory Roles of Nuclear Histone Genes in Bladder Cancer: A Bioinformatics Approach<br>Santhosh Mudipalli Elavarasu, Insha Asheem, Nihla M, Udhaya Kumar. S, R. Magesh, Sasikumar K, and George Priya Doss C<br>5. Identification of Common Hub Genes and Pathways in Systemic Lupus Erythematosus and Cervical Cancer Using Bioinformatics Approach<br>Tamizhini Loganathan, Madhulekha, Hatem Zayed, and George Priya Doss C<br>6. Transcriptomic Profiling Reveals Immune Pathway Dysregulation and Key Interferon-Responsive Genes in Systemic Lupus Erythematosus<br>Prasanna Kumar Selvam, Supraja Mohan and Karthick Vasudevan<br>7. Peptides and Peptidomimetics as Immunomodulator Agents Targeting Neglected Tropical Diseases<br>Sheila Oliveira de Souza, Leandro Rocha Silva, Manuele Figueiredo da Silva, <br>Maria Gabriele Cordeiro Domingos, Eziane Dantas da Silva, João Xavier de Araújo-Júnior, Paulo Fernando da Silva Santos-Júnior, Ana Catarina Rezende Leite, and <br>Edeildo Ferreira da Silva Júnior<br>8. Aptamers as immunomodulatory therapeutic alternatives targeting Neglected Tropical Diseases (NTDs)<br>Leandro Rocha Silva, Wadja Feitosa dos Santos Silva, Ana Clara Ferreira de Melo, <br>Érica Erlanny da Silva Rodrigues, and Edeildo Ferreira da Silva-Júnior